Physician profile
Fred M Arima
NPI 1568441350
$4,985.54
in general payments reported to CMS, 2019-2025
18 companies · $740 in 2025
The $740 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $293 · 2021: $368 · 2022: $681 · 2023: $776 · 2024: $1,313 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,795 · Entertainment: $33.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,795.37 |
| Entertainment | $33.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,208.06 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $1,059.25 | 2022-2025 | Miebo, Infuse, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $592.64 | 2019-2021 | |
| Lumenis Be INC | $574.79 | 2024 | Optilight |
| Johnson & Johnson Vision Care, INC. | $485.30 | 2020-2025 | Acuvue |
| Oyster Point Pharma, INC. | $214.01 | 2022 | |
| Optos, INC. | $195.12 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $186.02 | 2025 | Cirrus Hd-Oct |
| Sun Pharmaceutical Industries INC. | $116.04 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $100.20 | 2024 | Xdemvy |
| Biotissue Holdings INC. | $70.79 | 2021 | |
| Alcon Vision LLC | $49.43 | 2022-2024 | Dailies, Dailies Total1 |
| Johnson & Johnson Surgical Vision, INC. | $26.25 | 2023 | Lipiflow System Activator (Disposable) |
| Heru, INC. | $25.99 | 2022 | |
| Mallinckrodt Hospital Products INC. | $24.04 | 2025 | Acthar |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.97 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Arima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.